Efficacy of platelet-rich plasma on venous ulcers. Systematic review

Authors

DOI:

https://doi.org/10.59843/2618-3692.v25.n44.44146

Keywords:

venous ulcers, platelet-rich plasma, treatment, revision

Abstract

Introduction: Venous ulcers are painful open sores that are difficult to heal. Treatment can be challenging, depending on the complexity of the wound, and may require the use of several therapies. Recently, the use of platelet-rich plasma in these patients has been suggested as a novel treatment. The objective of this work is to carry out a review on the effectiveness of platelet-rich plasma in venous ulcers.

Method: A review was carried out following the PRISMA regulations. The databases of PubMed, Cinahl, PsycINFO, SPORTDiscus, Academic Search Complete, Lilacs, IBECS, CENTRAL, SciELO, and WOS were consulted. The Cochrane tool was used to assess the risk of bias.

Results: Platelet-rich plasma is effective in venous ulcers. The total sample was 311 patients from seven clinical trials. The duration of therapy ranges from 6 to 24 weeks. All studies showed safety, tolerability and no major side effects.

Conclusions: Platelet-rich plasma is an effective and safe method to accelerate healing, reduce the area of ulcers and reduce pain in patients. Furthermore, this therapy does not increase bacteriological growth or microbial load in chronic venous ulcers.

Downloads

Download data is not yet available.

Author Biographies

References

1. Bonkemeyer Millan S, Gan R, Townsend PE. Venous Ulcers: Diagnosis and Treatment. Am Fam Physician. 2019 Sep 1;100(5):298-305.

2. James CV, Murray Q, Park SY, Khajoueinejad N, Lee J, Ray K, et al. Venous leg ulcers: potential algorithms of care. Wounds. 2022 Dec;34(12):288-296. doi: 10.25270/wnds/21160.

3. Probst S, Saini C, Gschwind G, Stefanelli A, Bobbink P, Pugliese MT, et al. Prevalence and incidence of venous leg ulcers-A systematic review and meta-analysis. Int Wound J. 2023 Nov;20(9):3906-3921. doi: 10.1111/iwj.14272. Epub 2023 Jun 9.

4. Hess CT. Venous Ulcer Assessment and Management: Using the Updated CEAP Classification System. Adv Skin Wound Care. 2020 Nov;33(11):614-615. doi: 10.1097/01.ASW.0000719052.33284.73.

5. Turner BRH, Jasionowska S, Machin M, Javed A, Gwozdz AM, Shalhoub J, et al. Systematic review and meta-analysis of exercise therapy for venous leg ulcer healing and recurrence. J Vasc Surg Venous Lymphat Disord. 2023 Jan;11(1):219-226. doi: 10.1016/j.jvsv.2022.09.003.

6. Aleksandrowicz H, Owczarczyk-Saczonek A, Placek W. Venous Leg Ulcers: Advanced Therapies and New Technologies. Biomedicines. 2021 Oct 29;9(11):1569. doi: 10.3390/biomedicines9111569.

7. Ren SY, Liu YS, Zhu GJ, Liu M, Shi SH, Ren XD, et al. Strategies and challenges in the treatment of chronic venous leg ulcers. World J Clin Cases. 2020 Nov 6;8(21):5070-5085. doi: 10.12998/wjcc.v8.i21.5070.

8. Bossart S, Seyed Jafari SM, Lehmann M, Jossi-Will A, Sane E, Heidemeyer K, et al. Effect of topical application of platelet-rich plasma on chronic venous leg ulcerations. Dermatol Ther. 2022 Feb;35(2):e15236. doi: 10.1111/dth.15236.

9. Qu W, Wang Z, Hunt C, Morrow AS, Urtecho M, Amin M, et al. The Effectiveness and Safety of Platelet-Rich Plasma for Chronic Wounds: A Systematic Review and Meta-analysis. Mayo Clin Proc. 2021 Sep;96(9):2407-2417. doi: 10.1016/j.mayocp.2021.01.030.

10. Bolton L. Platelet-Rich Plasma: Optimal Use in Surgical Wounds. Wounds. 2021 Aug;33(8):219- 221.

11. Gupta S, Paliczak A, Delgado D. Evidence-based indications of platelet-rich plasma therapy. Expert Rev Hematol. 2021 Jan;14(1):97-108. Doi: 10.1080/17474086.2021.1860002.

12. Napit IB, Shrestha D, Neupane K, Adhikari A, Dhital R, Koirala R, et al. Autologous blood products: Leucocyte and Platelets Rich Fibrin (L-PRF) and Platelets Rich Plasma (PRP) gel to promote cutaneous ulcer healing - a systematic review. BMJ Open. 2023 Dec 12;13(12):e073209. doi: 10.1136/bmjopen-2023-073209.

13. Weller CD, Gardiner EE, Arthur JF, Southey M, Andrews RK. Autologous platelet-rich plasma for healing chronic venous leg ulcers: Clinical efficacy and potential mechanisms. Int Wound J. 2019 Jun;16(3):788-792. doi: 10.1111/iwj.13098.

14. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol. marzo de 2021;19:26.

15. Mamédio C, Andrucioli M, Cuce M. The PICO strategy for the research question construction and evidence research. Rev Latino-Am Enfermagem 2007;15:508- 11.

16. Higgins JPT, Thomas J. Cochrane Handbook for Systematic Reviews of Interventions. 2.aed. WILEY Blackwell; 2019.

17. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. diciembre de 2016;5(1):210.

18. Escamilla Cardeñosa M, Domínguez-Maldonado G, Córdoba-Fernández A. Efficacy and safety of the use of platelet-rich plasma to manage venous ulcers. J Tissue Viability. 2017 May;26(2):138- 143. doi: 10.1016/j.jtv.2016.11.003.

19. Oliveira MG, Abbade LPF, Miot HA, Ferreira RR, Deffune E. Pilot study of homologous platelet gel in venous ulcers. An Bras Dermatol. 2017 Jul-Aug;92(4):499-504. doi: 10.1590/abd1806- 4841.20175496.

20. Burgos-Alonso N, Lobato I, Hernández I, Sebastian KS, Rodríguez B, March AG, et al. Autologous platelet-rich plasma in the treatment of venous leg ulcers in primary care: a randomised controlled, pilot study. J Wound Care. 2018 Jun 1;27(Sup6):S20-S24. doi: 10.12968/jowc.2018.27.Sup6.S20.

21. Moneib HA, Youssef SS, Aly DG, Rizk MA, Abdelhakeem YI. Autologous platelet-rich plasma versus conventional therapy for the treatment of chronic venous leg ulcers: A comparative study. J Cosmet Dermatol. 2018 Jun;17(3):495-501. doi: 10.1111/jocd.12401.

22. Elgarhy LH, El-Ashmawy AA, Bedeer AE, Al-Bahnasy AM. Evaluation of safety and efficacy of autologous topical platelet gel vs platelet rich plasma injection in the treatment of venous leg ulcers: A randomized case control study. Dermatol Ther. 2020 Nov;33(6):e13897. doi: 10.1111/dth.13897.

23. Pires BMFB, Baptista de Oliveira BGR, Bokehi LC, Luiz RR, Carvalho BTF, Santana RF, et al. Clinical and Microbiological Outcomes Associated With Use of Platelet-Rich Plasma in Chronic Venous Leg Uclers: A Randomized Controlled Trial. J Wound Ostomy Continence Nurs. 2021 Jul- Aug 01;48(4):292-299. doi: 10.1097/WON.0000000000000774.

24. Shehab AW, Eleshra A, Fouda E, Elwakeel H, Farag M. Randomized prospective comparative study of platelet-rich plasma versus conventional compression in treatment of post-phlebitic venous ulcer. Vascular. 2023 Dec;31(6):1222-1229. Doi: 10.1177/17085381221104629.

25. Fang Q, Zhang Y, Tang L, Li X, Zhang X, Gang JJ, et al. Clinical Study of Platelet-Rich Plasma (PRP) for Lower Extremity Venous Ulcers: A Meta-Analysis and Systematic Review. Int J Low Extrem Wounds. 2023 Dec;22(4):641-653. doi: 10.1177/15347346211046203.

26. Li S, Xing F, Yan T, Zhang S, Chen F. The Efficiency and Safety of Platelet-Rich Plasma Dressing in the Treatment of Chronic Wounds: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Pers Med. 2023 Feb 27;13(3):430. doi: 10.3390/jpm13030430.

Downloads

Published

2024-09-27

Issue

Section

Artículos Originales

How to Cite

Efficacy of platelet-rich plasma on venous ulcers. Systematic review. (2024). Notas De Enfermería, 25(44), 19-30. https://doi.org/10.59843/2618-3692.v25.n44.44146